Related Experiment Video
Updated: Nov 25, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations
Wei Ping Khor1, Omotayo Olaoye1, Nikki D'Arcy1
1Commonwealth Pharmacists Association, London E1W 1AW, UK.
Abstract:
The coronavirus disease (COVID-19) pandemic, which has significant impact on global health care delivery, occurs amid the ongoing global health crisis of antimicrobial resistance. Early data demonstrated that bacterial and fungal co-infection with COVID-19 remain low and indiscriminate use of antimicrobials during the pandemic may worsen antimicrobial resistance It is, therefore, essential to maintain the ongoing effort of antimicrobial stewardship activities in all sectors globally.
Insights
The COVID-19 pandemic impacts healthcare, coinciding with a growing antimicrobial resistance crisis. Prudent antimicrobial use is vital to prevent worsening resistance during this global health challenge.
Area of Science:
- Global Health
- Infectious Diseases
- Microbiology
Background:
- The COVID-19 pandemic presents a significant challenge to global healthcare systems.
- This health crisis unfolds alongside the persistent global threat of antimicrobial resistance.
- Early evidence suggests low rates of bacterial and fungal co-infections in COVID-19 patients.
Purpose of the Study:
- To highlight the critical need for antimicrobial stewardship amidst the COVID-19 pandemic.
- To underscore the potential exacerbation of antimicrobial resistance due to indiscriminate antimicrobial use during the pandemic.
Main Methods:
- Review of early data on COVID-19 co-infections.
- Analysis of the impact of antimicrobial use during the pandemic on resistance trends.
Main Results:
- Bacterial and fungal co-infections in COVID-19 patients were found to be relatively low.
- Indiscriminate use of antimicrobials during the pandemic poses a risk of worsening antimicrobial resistance.
Conclusions:
- Maintaining and strengthening antimicrobial stewardship activities globally is essential.
- Continued vigilance and coordinated efforts are required across all sectors to combat antimicrobial resistance during and after the COVID-19 pandemic.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
08:32Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Endocarditis IV: Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Endocarditis III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Antimicrobial Effectiveness